Leo Niskanen

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Lennart Hansson, Lars Lindholm, Leo Niskanen et al. · The Lancet · 1999 · 2K citations

Hypertension, Cardiovascular Disease, Antihypertensive Agents +10

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

Jari Tiihonen, Jouko Lönnqvist, Kristian Wahlbeck et al. · The Lancet · 2009 · 1.3K citations

11-Year Follow-up, Psychiatric Evaluation, Psychiatry +7

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

Arne Astrup, Stephan Rössner, Luc Van Gaal et al. · The Lancet · 2009 · 1.1K citations

Obesity, Nutrition, Metabolic Syndrome +6

Testosterone and Sex Hormone–Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men

David E. Laaksonen, Leo Niskanen, Kari Punnonen et al. · Diabetes Care · 2004 · 918 citations · Full text

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

William T. Cefalu, Lawrence A. Leiter, Kun‐Ho Yoon et al. · The Lancet · 2013 · 718 citations

Metabolic Syndrome, Diabetes Management, Canagliflozin Versus Glimepiride +8